Cargando…
Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme
Synthetic biology offers exciting possibilities to deal with local and global challenges over the coming decades. As we make greater use of biological engineering, it will be increasingly important to balance potential risks and benefits. The rate, scale, and diffusion of relevant capabilities will...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996700/ https://www.ncbi.nlm.nih.gov/pubmed/36968257 http://dx.doi.org/10.1049/enb2.12012 |
_version_ | 1784903101269934080 |
---|---|
author | Millett, Piers Alexanian, Tessa |
author_facet | Millett, Piers Alexanian, Tessa |
author_sort | Millett, Piers |
collection | PubMed |
description | Synthetic biology offers exciting possibilities to deal with local and global challenges over the coming decades. As we make greater use of biological engineering, it will be increasingly important to balance potential risks and benefits. The rate, scale, and diffusion of relevant capabilities will make this challenging. There will be a growing need for flexible risk management approaches, which can be rapidly adapted as technology and societal needs change. This study details efforts by the International Genetically Engineered Machine (iGEM) competition in creating and implementing an adaptive risk management approach. It concludes with key lessons and challenges: working with hazardous materials, such as dangerous pathogens, toxins and chemicals; managing risks to plants, animals and the environment; use of samples from people, animals, and the environment; improving the hazards identified; variations in risk perception and tolerance; variation in terminology that complicates interpretation of risk management plans; and connections with broader societal or ethical questions, such as animal use, gender and sexuality, or benefit sharing. |
format | Online Article Text |
id | pubmed-9996700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99967002023-03-24 Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme Millett, Piers Alexanian, Tessa Eng Biol Case Study Synthetic biology offers exciting possibilities to deal with local and global challenges over the coming decades. As we make greater use of biological engineering, it will be increasingly important to balance potential risks and benefits. The rate, scale, and diffusion of relevant capabilities will make this challenging. There will be a growing need for flexible risk management approaches, which can be rapidly adapted as technology and societal needs change. This study details efforts by the International Genetically Engineered Machine (iGEM) competition in creating and implementing an adaptive risk management approach. It concludes with key lessons and challenges: working with hazardous materials, such as dangerous pathogens, toxins and chemicals; managing risks to plants, animals and the environment; use of samples from people, animals, and the environment; improving the hazards identified; variations in risk perception and tolerance; variation in terminology that complicates interpretation of risk management plans; and connections with broader societal or ethical questions, such as animal use, gender and sexuality, or benefit sharing. John Wiley and Sons Inc. 2021-09-01 /pmc/articles/PMC9996700/ /pubmed/36968257 http://dx.doi.org/10.1049/enb2.12012 Text en © 2021 The Authors. Engineering Biology published by John Wiley & Sons Ltd on behalf of The Institution of Engineering and Technology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Study Millett, Piers Alexanian, Tessa Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme |
title | Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme |
title_full | Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme |
title_fullStr | Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme |
title_full_unstemmed | Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme |
title_short | Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme |
title_sort | implementing adaptive risk management for synthetic biology: lessons from igem's safety and security programme |
topic | Case Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996700/ https://www.ncbi.nlm.nih.gov/pubmed/36968257 http://dx.doi.org/10.1049/enb2.12012 |
work_keys_str_mv | AT millettpiers implementingadaptiveriskmanagementforsyntheticbiologylessonsfromigemssafetyandsecurityprogramme AT alexaniantessa implementingadaptiveriskmanagementforsyntheticbiologylessonsfromigemssafetyandsecurityprogramme |